Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Fox

Showing results (81-90 of 182) with videos related to

Pageof 19
Sort By:
Journal of Viral Hepatitis|April 4, 2020
High incidence of Hepatitis C virus infection observed in the PROUD study of HIV pre-exposure prophylaxisMonica Desai, Ellen White, Nina Vora, et al.
AIDS and Behavior|March 10, 2025
Mapping Vaccination Mindsets among UK Residents of Black Ethnicities with HIV: Lessons from COVID-19Zoe Moon, Lucy Campbell, Zoe Ottaway, et al.
Virology Journal|February 10, 2025
Outcomes of switching from protease inhibitor-based antiretroviral therapy to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in virologically suppressed adults with nucleos(t)ide analogue resistance- a phase IV randomised, open-label study (PIBIK study)Collins Iwuji, Laura Waters, Ana Milinkovic, et al.
AIDS Research and Human Retroviruses|November 15, 2016
Analytical Advances in the Ex Vivo Challenge Efficacy AssayNicola Richardson-Harman, Robert Parody, Peter Anton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2016
Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV InfectionJohn Thornhill, Jamie Inshaw, Pontiano Kaleebu, et al.
Vaccines|February 28, 2023
Proteomic Analysis of Mucosal and Systemic Responses to SARS-CoV-2 AntigenNeil Martinson, Bhavna Gordhan, Stefan Petkov, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 28, 2024
Perspectives of People With HIV on Implementing Long-acting Cabotegravir Plus Rilpivirine in Clinics and Community Settings in the United Kingdom: Results From the Antisexist, Antiracist, Antiageist Implementing Long-acting Novel Antiretrovirals StudyChloe Orkin, Rosalie Hayes, Joanne Haviland, et al.
HIV Medicine|March 4, 2022
Re-valuation of annual cytology using HPV self-sampling to upgrade prevention (REACH UP): A feasibility study in women living with HIV in the UKPaola Cicconi, Charlotte Wells, Blanka McCarthy, et al.
International Journal of STD & AIDS|January 24, 2020
Surveying testing preferences in Black, Latin American, and other minorities for the co-design of digital vending machines for HIV self-testingMing J Lee, Denis Onyango, Husseina Hamza, et al.
HIV Medicine|March 26, 2024
HIV outcomes during the COVID-19 pandemic in people of Black ethnicities living with HIV in EnglandZoe Ottaway, Lucy Campbell, Julie Fox, et al.
Pageof 19

Showing results (81-90 of 182) with videos related to

Sort By:
Pageof 19
Journal of Viral Hepatitis|April 4, 2020
High incidence of Hepatitis C virus infection observed in the PROUD study of HIV pre-exposure prophylaxisMonica Desai, Ellen White, Nina Vora, et al.
AIDS and Behavior|March 10, 2025
Mapping Vaccination Mindsets among UK Residents of Black Ethnicities with HIV: Lessons from COVID-19Zoe Moon, Lucy Campbell, Zoe Ottaway, et al.
Virology Journal|February 10, 2025
Outcomes of switching from protease inhibitor-based antiretroviral therapy to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in virologically suppressed adults with nucleos(t)ide analogue resistance- a phase IV randomised, open-label study (PIBIK study)Collins Iwuji, Laura Waters, Ana Milinkovic, et al.
AIDS Research and Human Retroviruses|November 15, 2016
Analytical Advances in the Ex Vivo Challenge Efficacy AssayNicola Richardson-Harman, Robert Parody, Peter Anton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2016
Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV InfectionJohn Thornhill, Jamie Inshaw, Pontiano Kaleebu, et al.
Vaccines|February 28, 2023
Proteomic Analysis of Mucosal and Systemic Responses to SARS-CoV-2 AntigenNeil Martinson, Bhavna Gordhan, Stefan Petkov, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 28, 2024
Perspectives of People With HIV on Implementing Long-acting Cabotegravir Plus Rilpivirine in Clinics and Community Settings in the United Kingdom: Results From the Antisexist, Antiracist, Antiageist Implementing Long-acting Novel Antiretrovirals StudyChloe Orkin, Rosalie Hayes, Joanne Haviland, et al.
HIV Medicine|March 4, 2022
Re-valuation of annual cytology using HPV self-sampling to upgrade prevention (REACH UP): A feasibility study in women living with HIV in the UKPaola Cicconi, Charlotte Wells, Blanka McCarthy, et al.
International Journal of STD & AIDS|January 24, 2020
Surveying testing preferences in Black, Latin American, and other minorities for the co-design of digital vending machines for HIV self-testingMing J Lee, Denis Onyango, Husseina Hamza, et al.
HIV Medicine|March 26, 2024
HIV outcomes during the COVID-19 pandemic in people of Black ethnicities living with HIV in EnglandZoe Ottaway, Lucy Campbell, Julie Fox, et al.
Pageof 19